Promising Schizophrenia Drug, Cobenfy, Will Likely Face Access Challenges
Insurer access challenges likely lie ahead for the novel schizophrenia drug Cobenfy, given its considerably higher price than ...
Global Antipsychotic Drugs Market to Reach USD 29.23 Billion by 2032, Driven by Rising Mental Health Awareness and Drug Innovation – SNS Insider
According to Research by , The Antipsychotic Drugs Market is Expected to Grow at a CAGR of 6.53% Through 2032, Supported by Increasing Prevalence of Psychotic Disorders, Advancements in Medication ...
Medical Xpress21d
Meta-analysis reveals minimal cognitive gains from antipsychotic drugs
Antipsychotics, widely used to manage SSDs, are not considered or expected to be cognitive enhancers. Antipsychotics are primarily used to manage the core symptoms of SSDs, such as hallucinations ...
koco.com28d
Doctors confirm recent cases of atypical pneumonia in Oklahoma
A TYPICAL PATIENTS HAVE MUCH MILDER SYMPTOMS. THEY MAY NOT EVEN HAVE A SIGNIFICANT TEMPERATURE. DOCTOR WHITSON SAYS ATYPICAL PNEUMONIA IS A LITTLE HARDER TO FIGURE OUT THAN A USUAL CASE. MORE ...